F.D.A. Approves an Immunotherapy Drug for Bladder Cancer

The drug, Tecentriq from Roche, works by using the body’s immune system against tumors, and is the first drug of its type approved for bladder cancer.

from NYT > Health http://ift.tt/1quDeBj
via health&fitness